Finding a safe and effective treatment for COVID-19 remains a top priority for policymakers in the U.S. As the nation comes closer to a vaccine, many individuals have volunteered to join clinical trials. However, racial and ethnic minority groups have been underrepresented in these trials. During this webinar, hear from experts on how clinical trials operate, current COVID-19 clinical trials and efforts to include broader demographics in the research.
VIEW WEBINAR AS PDF
- George Mensah, MD, director, Center for Translation Research and Implementation Science, National Heart, Lung, and Blood Institute (NHLBI), NIH
- Badhri Srinivasan, head of global development operations, Novartis